Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy.
Lai
Ming-Yu
MY
Yang
Wu-Chang
WC
Lee
Shon-Dong
SD
Ng
Yee-Yung
YY
D004351:Drug Resistance; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D009401:Nephrosis / Q000188:drug therapy* / Q000821:virology; D055502:Secondary Prevention; D013997:Time Factors
D019259:Lamivudine